Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris Medical Dialogues Bureau16 Nov 2019 9:20 AM ISTNew Delhi: Mylan N.V. and Pfizer Inc. recently announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn,...
Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore Medical Dialogues Bureau14 Nov 2019 9:30 AM ISTManaging director of Aurobindo Pharma N Govindarajan said We had another quarter of healthy performance where we continued to grow in the US and...
Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US Medical Dialogues Bureau13 Nov 2019 9:33 AM IST"The decline in revenues and profits compared to the same period last year is primarily due to the anticipated drop in oseltamivir product sales in...
RedHill Biopharma Talicia wins USFDA nod for treating bacterial infection Medical Dialogues Bureau11 Nov 2019 9:15 AM ISTThe drug, Talicia, is an oral capsule comprising two antibiotics, amoxicillin and rifabutin, as well as omeprazole, a common treatment for...
Laurus Labs gets 2 USFDA observations for Visakhapatnam facility Farhat Nasim10 Nov 2019 10:00 AM ISTNew Delhi: Drug firm, Laurus Labs Ltd. recently said in a filing that the US health regulator has issued two observations after the inspection of its...
Aurobindo Pharma USA recalls heartburn drug Ranitidine over cancer causing impurities Medical Dialogues Bureau10 Nov 2019 9:45 AM ISTAurobindo Pharma is second city-based drug company that has initiated the voluntary recall after the FDA announced an investigation into the reported...
Abbott discovers new strain of HIV, keeping global health community step ahead of virus Medical Dialogues Bureau10 Nov 2019 9:00 AM ISTNew Delhi: Abbott announced recently that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1...
Shilpa Medicare gets USFDA approval for generic equivalent of cancer drug TARCEVA Farhat Nasim8 Nov 2019 10:00 AM ISTErlotinib Tablets, 25 mg, 100 mg, and 150 mg is a generic equivalent of reference listed drug (RLD) TARCEVA used in the treatment of patients with...
Penalty levied by SEBI on Jubilant Life Sciences reduced to Rs 5 lakh Medical Dialogues Bureau8 Nov 2019 9:30 AM IST"We have found that the appellant in... Jubilant Life Sciences would be liable for a penalty only on one count i.e. for non-disclosure of the China...
New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble Medical Dialogues Bureau7 Nov 2019 4:20 PM ISTCadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd. and Lupin Ltd. are the latest local medicine makers to be reprimanded by the US Food and Drug...
Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China Medical Dialogues Bureau6 Nov 2019 1:26 PM ISTMumbai-Indian drugmaker giant Sun Pharma announced today about entering into an agreement with AstraZeneca to enter the Chinese market with novel...
Novartis gets U.S. nod for long-delayed copycat version of Amgen billion seller Neulasta drug Medical Dialogues Bureau6 Nov 2019 10:32 AM ISTZURICH: Novartis on Tuesday won U.S. approval for its long-delayed version of Amgen's $4 billion seller Neulasta drug, helping the Swiss drugmaker in...
